chrX-153865088-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001278116.2(L1CAM):​c.2872C>G​(p.Leu958Val) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00184 in 1,209,807 control chromosomes in the GnomAD database, including 31 homozygotes. There are 636 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.010 ( 15 hom., 332 hem., cov: 23)
Exomes 𝑓: 0.0010 ( 16 hom. 304 hem. )

Consequence

L1CAM
NM_001278116.2 missense, splice_region

Scores

15
Splicing: ADA: 0.00003188
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -3.58

Publications

5 publications found
Variant links:
Genes affected
L1CAM (HGNC:6470): (L1 cell adhesion molecule) The protein encoded by this gene is an axonal glycoprotein belonging to the immunoglobulin supergene family. The ectodomain, consisting of several immunoglobulin-like domains and fibronectin-like repeats (type III), is linked via a single transmembrane sequence to a conserved cytoplasmic domain. This cell adhesion molecule plays an important role in nervous system development, including neuronal migration and differentiation. Mutations in the gene cause X-linked neurological syndromes known as CRASH (corpus callosum hypoplasia, retardation, aphasia, spastic paraplegia and hydrocephalus). Alternative splicing of this gene results in multiple transcript variants, some of which include an alternate exon that is considered to be specific to neurons. [provided by RefSeq, May 2013]
L1CAM Gene-Disease associations (from GenCC):
  • L1 syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • X-linked hydrocephalus with stenosis of the aqueduct of Sylvius
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
  • MASA syndrome
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
  • X-linked complicated corpus callosum dysgenesis
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • X-linked complicated spastic paraplegia type 1
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017657876).
BP6
Variant X-153865088-G-C is Benign according to our data. Variant chrX-153865088-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 92928.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.01 (1134/113001) while in subpopulation AFR AF = 0.0349 (1090/31208). AF 95% confidence interval is 0.0332. There are 15 homozygotes in GnomAd4. There are 332 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 15 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001278116.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
L1CAM
NM_001278116.2
MANE Select
c.2872C>Gp.Leu958Val
missense splice_region
Exon 22 of 29NP_001265045.1
L1CAM
NM_000425.5
c.2872C>Gp.Leu958Val
missense splice_region
Exon 21 of 28NP_000416.1
L1CAM
NM_024003.3
c.2872C>Gp.Leu958Val
missense splice_region
Exon 21 of 27NP_076493.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
L1CAM
ENST00000370060.7
TSL:5 MANE Select
c.2872C>Gp.Leu958Val
missense splice_region
Exon 22 of 29ENSP00000359077.1
L1CAM
ENST00000361699.8
TSL:1
c.2872C>Gp.Leu958Val
missense splice_region
Exon 21 of 27ENSP00000355380.4
L1CAM
ENST00000361981.7
TSL:1
c.2857C>Gp.Leu953Val
missense splice_region
Exon 20 of 26ENSP00000354712.3

Frequencies

GnomAD3 genomes
AF:
0.0100
AC:
1131
AN:
112947
Hom.:
15
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0349
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00297
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00720
GnomAD2 exomes
AF:
0.00261
AC:
466
AN:
178603
AF XY:
0.00197
show subpopulations
Gnomad AFR exome
AF:
0.0339
Gnomad AMR exome
AF:
0.000989
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000127
Gnomad OTH exome
AF:
0.000450
GnomAD4 exome
AF:
0.00100
AC:
1097
AN:
1096806
Hom.:
16
Cov.:
34
AF XY:
0.000838
AC XY:
304
AN XY:
362640
show subpopulations
African (AFR)
AF:
0.0353
AC:
931
AN:
26394
American (AMR)
AF:
0.00148
AC:
52
AN:
35172
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19352
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30190
South Asian (SAS)
AF:
0.000111
AC:
6
AN:
54109
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
39511
Middle Eastern (MID)
AF:
0.000726
AC:
3
AN:
4131
European-Non Finnish (NFE)
AF:
0.0000131
AC:
11
AN:
841884
Other (OTH)
AF:
0.00204
AC:
94
AN:
46063
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
59
119
178
238
297
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0100
AC:
1134
AN:
113001
Hom.:
15
Cov.:
23
AF XY:
0.00944
AC XY:
332
AN XY:
35163
show subpopulations
African (AFR)
AF:
0.0349
AC:
1090
AN:
31208
American (AMR)
AF:
0.00296
AC:
32
AN:
10794
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2646
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3574
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2767
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6338
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.0000188
AC:
1
AN:
53224
Other (OTH)
AF:
0.00712
AC:
11
AN:
1546
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
35
70
106
141
176
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000736
Hom.:
15
Bravo
AF:
0.0112
ESP6500AA
AF:
0.0308
AC:
118
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00280
AC:
339
EpiCase
AF:
0.00
EpiControl
AF:
0.000119

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jun 04, 2015
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:2
Nov 14, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Aug 01, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Spastic paraplegia Benign:1
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Inborn genetic diseases Benign:1
Jun 21, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Hereditary spastic paraplegia Benign:1
Jun 26, 2017
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.73
T
BayesDel_noAF
Benign
-0.79
CADD
Benign
0.0010
DANN
Benign
0.52
DEOGEN2
Benign
0.29
T
FATHMM_MKL
Benign
0.013
N
LIST_S2
Benign
0.79
T
MetaRNN
Benign
0.0018
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.30
N
PhyloP100
-3.6
PrimateAI
Benign
0.33
T
PROVEAN
Benign
0.93
N
REVEL
Benign
0.033
Sift
Benign
0.37
T
Sift4G
Benign
0.55
T
Polyphen
0.0030
B
Vest4
0.060
MVP
0.39
MPC
0.55
ClinPred
0.0030
T
GERP RS
-9.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.057
gMVP
0.50
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000032
dbscSNV1_RF
Benign
0.13
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35902890; hg19: chrX-153130543; API